Omeros Corp (OMER)
2.98
-0.06
(-1.97%)
USD |
NASDAQ |
Apr 25, 09:52
Omeros Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2020 | -1.957 |
| September 30, 2020 | -2.666 |
| June 30, 2020 | -1.013 |
| March 31, 2020 | -1.219 |
| December 31, 2019 | -1.451 |
| September 30, 2019 | -1.113 |
| June 30, 2019 | -1.178 |
| March 31, 2019 | -1.249 |
| December 31, 2018 | -1.488 |
| September 30, 2018 | -1.469 |
| June 30, 2018 | -2.290 |
| March 31, 2018 | -2.888 |
| December 31, 2017 | -29.60 |
| September 30, 2017 | 8.929 |
| June 30, 2017 | -1.480 |
| March 31, 2017 | -1.666 |
| December 31, 2016 | -2.115 |
| September 30, 2016 | -3.095 |
| June 30, 2016 | -1.429 |
| March 31, 2016 | -1.228 |
| December 31, 2015 | -1.889 |
| September 30, 2015 | -3.171 |
| June 30, 2015 | 3.879 |
| March 31, 2015 | 1.507 |
| December 31, 2014 | -0.7608 |
| Date | Value |
|---|---|
| September 30, 2014 | -1.224 |
| June 30, 2014 | -3.051 |
| March 31, 2014 | 6.180 |
| December 31, 2013 | -1.115 |
| September 30, 2013 | -0.8536 |
| June 30, 2013 | -1.656 |
| March 31, 2013 | -1.273 |
| December 31, 2012 | -3.078 |
| September 30, 2012 | -18.36 |
| June 30, 2012 | -0.8061 |
| March 31, 2012 | -1.421 |
| December 31, 2011 | -3.501 |
| September 30, 2011 | 4.996 |
| June 30, 2011 | 2.028 |
| March 31, 2011 | 1.381 |
| December 31, 2010 | 0.4766 |
| September 30, 2010 | 0.3902 |
| June 30, 2010 | 0.3404 |
| March 31, 2010 | 0.3104 |
| December 31, 2009 | 0.2957 |
| September 30, 2009 | -0.1329 |
| June 30, 2009 | -0.1495 |
| March 31, 2009 | |
| December 31, 2008 | -0.1829 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-2.666
Minimum
Sep 2020
-1.013
Maximum
Jun 2020
-1.514
Average
-1.219
Median
Mar 2020
Debt to Equity Ratio Benchmarks
| Aspira Womens Health Inc | -0.9581 |
| Ardelyx Inc | 0.2987 |
| Panbela Therapeutics Inc | -- |
| Ensysce Biosciences Inc | -- |
| MAIA Biotechnology Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 378.27M |
| Total Liabilities (Quarterly) | 403.25M |
| Shareholders Equity (Quarterly) | -24.98M |